NDAQ Nasdaq Inc.

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Bra

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market

NEW YORK,, March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.’s securities were suspended on August 10, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Eloxx Pharmaceuticals, Inc. Eloxx Pharmaceuticals, Inc.’s securities were suspended on October 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of Collective Audience, Inc. Collective Audience, Inc.’s warrants were suspended on November 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of SeqLL Inc. SeqLL Inc.’s securities were suspended on November 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Nemaura Medical Inc. Nemaura Medical Inc.’s securities were suspended on January 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of LumiraDx Limited. LumiraDx Limited’s securities were suspended on January 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Series 1 Preferred Stock of Cemtrex Inc. Cemtrex Inc.’s shares of Series 1 Preferred Stock were suspended on January 22, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the perpetual preferred stock, common stock, and warrants of COMSovereign Holding Corp. COMSovereign Holding Corp.’s shares of perpetual preferred stock were suspended on January 23, 2024; the company’s shares of common stock and warrants were suspended on January 31, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, units, and warrants of Global System Dynamics. Global System Dynamics’s securities were suspended on January 24, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Arrival. Arrival’s securities were suspended on January 30, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrant of Nubia Brand International Corp. Nubia Brand International Corp.’s securities were suspended on February 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of The Alkaline Water Company Inc. The Alkaline Water Company Inc.’s securities were suspended on February 6, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of DMK Pharmaceuticals Corporation. DMK Pharmaceuticals Corporation’s securities were suspended on February 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of MedAvail Holdings, Inc. MedAvail Holdings, Inc.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ADDvantage Technologies Group, Inc. ADDvantage Technologies Group, Inc.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .



EN
20/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE

Nasdaq Reports February 2026 Volumes

Nasdaq Reports February 2026 Volumes NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for February 2026 on its Investor Relations website. A data sheet showing this information can be found at: .   About Nasdaq  Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world’s economies. We architect the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying markets, technology, data, and advanced analytics that enable our c...

 PRESS RELEASE

Nasdaq Texas Launches with Inaugural Dual Listings

Nasdaq Texas Launches with Inaugural Dual Listings Nasdaq Texas Celebrates Official Launch with the Nasdaq Stock Market Closing Bell at the Alamo with the First Cohort of Dual Listings Nasdaq, Inc. to Dual List on Nasdaq Texas Alongside Inaugural Group SAN ANTONIO, March 05, 2026 (GLOBE NEWSWIRE) -- Nasdaq Texas will mark another milestone by ringing the Nasdaq Closing Bell at The Alamo, San Antonio, Texas, commemorating the 190th anniversary of the Battle of the Alamo and the full operational launch of Nasdaq Texas following approval of its listing rules from the U.S. Securities and Ex...

 PRESS RELEASE

Nasdaq Executives to Present at Upcoming Investor Conferences

Nasdaq Executives to Present at Upcoming Investor Conferences NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in March with webcasts available at Nasdaq’s Investor Relations website: . Who:Sarah Youngwood, Executive Vice President & Chief Financial Officer, NasdaqWhat:Morgan Stanley Technology, Media & Telecom ConferenceWhen:Monday, March 2nd, 11:30 AM ET  Who:Jeremy Skule, Executive Vice President, Chief Strategy Officer & Executive Chair, Financial Crime Management Technology, NasdaqWhat:Raymond James 47thAnnual Instituti...

 PRESS RELEASE

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Sto...

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 13, 2026 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 13, 2026, short interest in 3,595 Nasdaq Global MarketSM securities totaled 15,834,216,597 shares compared with 15,574,683,465 shares in 3,547 Global Market issues reported for the prior settlement date of January 30, 2026. The mid-January short interest represents 2.25 days compared with 2.58 days for the prior reporting period. Short interest in 1,654 securities on The Nasdaq Capital M...

 PRESS RELEASE

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for It...

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day Nasdaq raises medium-term Solutions revenue outlook to 9-12% growthMaintains medium-term outlook for expense growth of 5-8%Company reinforces its position as trusted transformation partner in the AI eraCommits to actioning AI productivity program with an expense efficiency target of $100 million by 2027 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today will host its Investor Day at 8:00 a.m. ET, where Adena Friedman, Nasdaq Chair and CEO, Sarah ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch